Breaking Down Translation Barriers: Investigator’s Perspective
- 3 September 2014
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 6 (252), 252cm7
- https://doi.org/10.1126/scitranslmed.3008252
Abstract
Biomedical scientists can exploit initiatives from U.S. federal regulatory and funding agencies aimed at accelerating clinical translation.Keywords
This publication has 9 references indexed in Scilit:
- A systematic review of animal models used to study nerve regeneration in tissue-engineered scaffoldsBiomaterials, 2012
- NeuroNEXT: accelerating drug development in neurologyThe Lancet Neurology, 2012
- Can Animal Models of Disease Reliably Inform Human Studies?PLoS Medicine, 2010
- Medicare Advantage: Reforms Needed to Ensure Access to Clinical TrialsJournal of Oncology Practice, 2009
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trialNeurology, 2008
- Practice-Based Research—“Blue Highways” on the NIH RoadmapJama-Journal Of The American Medical Association, 2007
- From the Schools of Public HealthPublic Health Reports, 2006
- The NIH RoadmapScience, 2003
- Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase MutationScience, 1994